Drug Shortage Report for MAXALT RPD

Last updated on 2021-04-07 History
Report ID 137105
Drug Identification Number 02240518
Brand name MAXALT RPD
Common or Proper name rizatriptan benzoate wafers
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 12
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-06-04
Actual start date
Estimated end date 2021-07-16
Actual end date
Shortage status Anticipated shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-04-07 English Compare
v2 2021-04-07 French Compare